Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wesolowski

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|October 29, 2010
Developing dual functional allosteric modulators of GABA(A) receptorsXiaodong F Liu, Hui-Fang Chang, Richard Jon Schmiesing, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1980
Development of collagenous linings on impermeable prosthetic surfacesW F Bernhard, N A Colo, J S Wesolowski, et al.
Annals of Surgery|September 1, 1980
Development of a nonthrombogenic collagenous blood-prosthetic interfaceW F Bernhard, N A Colo, M Szycher, et al.
Frontiers in Molecular Neuroscience|March 14, 2017
Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS <i>In vitro</i>Heike J Wobst, Steven S Wesolowski, Jayashree Chadchankar, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2012
Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonistsRebecca A Urbanek, Hui Xiong, Ye Wu, et al.
Protein Engineering, Design & Selection : PEDS|April 19, 2011
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodiesMarco Muda, Alec W Gross, Jessica P Dawson, et al.
Scientific Reports|November 21, 2023
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignanciesSamantha M Goodstal, Jing Lin, Timothy Crandall, et al.
Molecular Pharmacology|March 17, 2018
Differential Pharmacology and Binding of mGlu<sub>2</sub> Receptor Allosteric ModulatorsDaniel E O'Brien, Douglas M Shaw, Hyekyung P Cho, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2018
Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screeningRoland W Bürli, Huijun Wei, Glen Ernst, et al.
ACS Chemical Neuroscience|November 4, 2015
Discovery and Preclinical Validation of [(11)C]AZ13153556, a Novel Probe for the Histamine Type 3 ReceptorMagnus Schou, Katarina Varnäs, Anders Jureus, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|October 29, 2010
Developing dual functional allosteric modulators of GABA(A) receptorsXiaodong F Liu, Hui-Fang Chang, Richard Jon Schmiesing, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 1, 1980
Development of collagenous linings on impermeable prosthetic surfacesW F Bernhard, N A Colo, J S Wesolowski, et al.
Annals of Surgery|September 1, 1980
Development of a nonthrombogenic collagenous blood-prosthetic interfaceW F Bernhard, N A Colo, M Szycher, et al.
Frontiers in Molecular Neuroscience|March 14, 2017
Cytoplasmic Relocalization of TAR DNA-Binding Protein 43 Is Not Sufficient to Reproduce Cellular Pathologies Associated with ALS <i>In vitro</i>Heike J Wobst, Steven S Wesolowski, Jayashree Chadchankar, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2012
Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonistsRebecca A Urbanek, Hui Xiong, Ye Wu, et al.
Protein Engineering, Design & Selection : PEDS|April 19, 2011
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodiesMarco Muda, Alec W Gross, Jessica P Dawson, et al.
Scientific Reports|November 21, 2023
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignanciesSamantha M Goodstal, Jing Lin, Timothy Crandall, et al.
Molecular Pharmacology|March 17, 2018
Differential Pharmacology and Binding of mGlu<sub>2</sub> Receptor Allosteric ModulatorsDaniel E O'Brien, Douglas M Shaw, Hyekyung P Cho, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2018
Novel inhibitors of As(III) S-adenosylmethionine methyltransferase (AS3MT) identified by virtual screeningRoland W Bürli, Huijun Wei, Glen Ernst, et al.
ACS Chemical Neuroscience|November 4, 2015
Discovery and Preclinical Validation of [(11)C]AZ13153556, a Novel Probe for the Histamine Type 3 ReceptorMagnus Schou, Katarina Varnäs, Anders Jureus, et al.
Pageof 9